George R. Stark - Publications

Affiliations: 
Stanford, ICRF, Cleveland Clinic 
Area:
signal transducers and activators of transcription
Website:
http://www.jbc.org/cgi/ijlink?linkType=FULL&journalCode=jbc&resid=280/11/9753

113 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2023 Wang C, Nan J, Holvey-Bates E, Chen X, Wightman S, Latif MB, Zhao J, Li X, Sen GC, Stark GR, Wang Y. STAT2 hinders STING intracellular trafficking and reshapes its activation in response to DNA damage. Proceedings of the National Academy of Sciences of the United States of America. 120: e2216953120. PMID 37036972 DOI: 10.1073/pnas.2216953120  0.306
2020 Wang Y, Song Q, Huang W, Lin Y, Wang X, Wang C, Willard B, Zhao C, Nan J, Holvey-Bates E, Wang Z, Taylor D, Yang J, Stark GR. A virus-induced conformational switch of STAT1-STAT2 dimers boosts antiviral defenses. Cell Research. PMID 32759968 DOI: 10.1038/S41422-020-0386-6  0.356
2020 Jaini R, Loya MG, King AT, Thacker S, Sarn NB, Yu Q, Stark GR, Eng C. Germline PTEN mutations are associated with a skewed peripheral immune repertoire in humans and mice. Human Molecular Genetics. PMID 32588888 DOI: 10.1093/Hmg/Ddaa118  0.328
2020 Zhu N, Zhang J, Du Y, Qin X, Miao R, Nan J, Chen X, Sun J, Zhao R, Zhang X, Shi L, Li X, Lin Y, Wei W, Mao A, ... ... Stark GR, et al. Loss of ZIP facilitates JAK2-STAT3 activation in tamoxifen-resistant breast cancer. Proceedings of the National Academy of Sciences of the United States of America. PMID 32532922 DOI: 10.1073/Pnas.1910278117  0.303
2020 Kondratova AA, Cheon H, Dong B, Holvey-Bates EG, Hasipek M, Taran I, Gaughan C, Jha BK, Silverman RH, Stark GR. Suppressing PARylation by 2',5'-oligoadenylate synthetase 1 inhibits DNA damage-induced cell death. The Embo Journal. e101573. PMID 32323871 DOI: 10.15252/Embj.2019101573  0.347
2019 Davuluri G, Giusto M, Chandel R, Welch N, Alsabbagh K, Kant S, Kumar A, Kim A, Gangadhariah M, Ghosh PK, Tran U, Krajcik DM, Vasu K, DiDonato AJ, DiDonato J, ... ... Stark GR, et al. Impaired Ribosomal Biogenesis by Non-Canonical Degradation of β-catenin during Hyperammonemia. Molecular and Cellular Biology. PMID 31138664 DOI: 10.1128/Mcb.00451-18  0.304
2019 Banerjee S, Gusho E, Gaughan C, Dong B, Gu X, Holvey-Bates E, Talukdar M, Li Y, Weiss SR, Sicheri F, Saunthararajah Y, Stark GR, Silverman RH. OAS-RNase L innate immune pathway mediates the cytotoxicity of a DNA-demethylating drug. Proceedings of the National Academy of Sciences of the United States of America. PMID 30814222 DOI: 10.1073/Pnas.1815071116  0.356
2018 Liao L, Liu ZZ, Langbein L, Cai W, Cho EA, Na J, Niu X, Jiang W, Zhong Z, Cai WL, Jagannathan G, Dulaimi E, Testa JR, Uzzo RG, Wang Y, ... Stark GR, et al. Multiple tumor suppressors regulate a HIF-dependent negative feedback loop via ISGF3 in human clear cell renal cancer. Elife. 7. PMID 30355451 DOI: 10.7554/Elife.37925  0.319
2017 Chen M, Liang J, Ji H, Yang Z, Altilia S, Hu B, Schronce A, McDermott MSJ, Schools GP, Lim CU, Oliver D, Shtutman MS, Lu T, Stark GR, Porter DC, et al. CDK8/19 Mediator kinases potentiate induction of transcription by NFκB. Proceedings of the National Academy of Sciences of the United States of America. PMID 28855340 DOI: 10.1073/Pnas.1710467114  0.377
2017 Doherty MR, Junk DJ, Cheon H, Stark GR, Jackson MW. Abstract 2884: Interferon Beta (IFN-B) re-activates canonical type I IFN signaling to differentiate breast cancer stem cells (CSCs) and suppress mesenchymal/CSC driven tumor recurrence Cancer Research. 77: 2884-2884. DOI: 10.1158/1538-7445.Am2017-2884  0.338
2016 Wang Y, Nan J, Willard B, Wang X, Yang J, Stark GR. Negative regulation of type I IFN signaling by phosphorylation of STAT2 on T387. The Embo Journal. PMID 27852626 DOI: 10.15252/Embj.201694834  0.36
2015 Wienerroither S, Shukla P, Farlik M, Majoros A, Stych B, Vogl C, Cheon H, Stark GR, Strobl B, Müller M, Decker T. Cooperative Transcriptional Activation of Antimicrobial Genes by STAT and NF-κB Pathways by Concerted Recruitment of the Mediator Complex. Cell Reports. 12: 300-12. PMID 26146080 DOI: 10.1016/J.Celrep.2015.06.021  0.37
2015 Dasgupta M, Dermawan JK, Willard B, Stark GR. STAT3-driven transcription depends upon the dimethylation of K49 by EZH2. Proceedings of the National Academy of Sciences of the United States of America. 112: 3985-90. PMID 25767098 DOI: 10.1073/Pnas.1503152112  0.317
2015 De S, Zhou H, Li X, Stark G. Abstract 1944: NFκB: Activation by EGF requires TLR4 and activation by LPS requires EGFR Cancer Research. 75: 1944-1944. DOI: 10.1158/1538-7445.Am2015-1944  0.306
2015 Wienerroither S, Shukla P, Farlik M, Majoros A, Vogl C, Cheon H, Stark G, Strobl B, Müller M, Decker T. ID: 54 Cytokine. 76: 74. DOI: 10.1016/J.Cyto.2015.08.084  0.383
2014 De S, Dermawan JK, Stark GR. EGF receptor uses SOS1 to drive constitutive activation of NFκB in cancer cells. Proceedings of the National Academy of Sciences of the United States of America. 111: 11721-6. PMID 25071181 DOI: 10.1073/Pnas.1412390111  0.333
2014 Cheon H, Holvey-Bates EG, Stark GR. Abstract 485: Chronic exposure to a low dose of interferon-β increases levels of DNA damage resistance signature genes through unphosphorylated ISGF3 Cancer Research. 74: 485-485. DOI: 10.1158/1538-7445.Am2014-485  0.38
2014 Wei H, Wang B, Miyagi M, She Y, Gopalan B, Huang D, Ghosh G, Stark G, Lu T. 120 Cytokine. 70: 56. DOI: 10.1016/J.Cyto.2014.07.127  0.362
2013 Wang Y, van Boxel-Dezaire AH, Cheon H, Yang J, Stark GR. STAT3 activation in response to IL-6 is prolonged by the binding of IL-6 receptor to EGF receptor. Proceedings of the National Academy of Sciences of the United States of America. 110: 16975-80. PMID 24082147 DOI: 10.1073/Pnas.1315862110  0.3
2013 Cheon H, Holvey-Bates EG, Schoggins JW, Forster S, Hertzog P, Imanaka N, Rice CM, Jackson MW, Junk DJ, Stark GR. IFNβ-dependent increases in STAT1, STAT2, and IRF9 mediate resistance to viruses and DNA damage. The Embo Journal. 32: 2751-63. PMID 24065129 DOI: 10.1038/Emboj.2013.203  0.391
2013 Wei H, Wang B, Miyagi M, She Y, Gopalan B, Huang DB, Ghosh G, Stark GR, Lu T. PRMT5 dimethylates R30 of the p65 subunit to activate NF-κB. Proceedings of the National Academy of Sciences of the United States of America. 110: 13516-21. PMID 23904475 DOI: 10.1073/Pnas.1311784110  0.351
2013 Zhang T, Park KA, Li Y, Byun HS, Jeon J, Lee Y, Hong JH, Kim JM, Huang SM, Choi SW, Kim SH, Sohn KC, Ro H, Lee JH, Lu T, ... Stark GR, et al. PHF20 regulates NF-κB signalling by disrupting recruitment of PP2A to p65. Nature Communications. 4: 2062. PMID 23797602 DOI: 10.1038/Ncomms3062  0.338
2013 Van Boxel-Dezaire AH, Stark GR. 263 Cytokine. 63: 305. DOI: 10.1016/J.Cyto.2013.06.266  0.328
2013 Dermawan JK, Stark GR. 66 Cytokine. 63: 259. DOI: 10.1016/J.Cyto.2013.06.069  0.33
2013 Cheon H, Holvey-Bates EG, Stark GR. 44 Cytokine. 63: 253-254. DOI: 10.1016/J.Cyto.2013.06.047  0.379
2012 Stark GR, Darnell JE. The JAK-STAT pathway at twenty. Immunity. 36: 503-14. PMID 22520844 DOI: 10.1016/J.Immuni.2012.03.013  0.369
2011 Cheon H, Holvey-Bates E, Junk D, Jackson M, Stark G. CS07-5. Loss of p53 increases unphosphorylated STAT1, which induces resistance to DNA damage in cancer cells Cytokine. 56: 52. DOI: 10.1016/J.Cyto.2011.07.342  0.325
2010 Yang J, Huang J, Dasgupta M, Sears N, Miyagi M, Wang B, Chance MR, Chen X, Du Y, Wang Y, An L, Wang Q, Lu T, Zhang X, Wang Z, ... Stark GR, et al. Reversible methylation of promoter-bound STAT3 by histone-modifying enzymes. Proceedings of the National Academy of Sciences of the United States of America. 107: 21499-504. PMID 21098664 DOI: 10.1073/Pnas.1016147107  0.309
2010 Wan Y, Yang M, Kolattukudy S, Stark GR, Lu T. Activation of cAMP-responsive-element-binding protein by PI3 kinase and p38 MAPK is essential for elevated expression of transforming growth factor β2 in cancer cells. Journal of Interferon & Cytokine Research : the Official Journal of the International Society For Interferon and Cytokine Research. 30: 677-81. PMID 20629536 DOI: 10.1089/Jir.2009.0117  0.351
2009 Cheon H, Stark GR. Unphosphorylated STAT1 prolongs the expression of interferon-induced immune regulatory genes. Proceedings of the National Academy of Sciences of the United States of America. 106: 9373-8. PMID 19478064 DOI: 10.1073/pnas.0903487106  0.353
2008 Yang J, Stark GR. Roles of unphosphorylated STATs in signaling. Cell Research. 18: 443-51. PMID 18364677 DOI: 10.1038/Cr.2008.41  0.361
2007 van Boxel-Dezaire AH, Stark GR. Cell type-specific signaling in response to interferon-gamma. Current Topics in Microbiology and Immunology. 316: 119-54. PMID 17969446 DOI: 10.1007/978-3-540-71329-6_7  0.385
2007 Stark GR. How cells respond to interferons revisited: from early history to current complexity. Cytokine & Growth Factor Reviews. 18: 419-23. PMID 17683974 DOI: 10.1016/J.Cytogfr.2007.06.013  0.365
2007 Agrawal S, Febbraio M, Podrez E, Cathcart MK, Stark GR, Chisolm GM. Signal transducer and activator of transcription 1 is required for optimal foam cell formation and atherosclerotic lesion development. Circulation. 115: 2939-47. PMID 17533179 DOI: 10.1161/Circulationaha.107.696922  0.314
2006 Stark GR, Taylor WR. Control of the G2/M transition. Molecular Biotechnology. 32: 227-48. PMID 16632889 DOI: 10.1385/Mb:32:3:227  0.348
2005 Marques JT, Rebouillat D, Ramana CV, Murakami J, Hill JE, Gudkov A, Silverman RH, Stark GR, Williams BR. Down-regulation of p53 by double-stranded RNA modulates the antiviral response. Journal of Virology. 79: 11105-14. PMID 16103161 DOI: 10.1128/Jvi.79.17.11105-11114.2005  0.349
2005 Jackson MW, Agarwal MK, Yang J, Bruss P, Uchiumi T, Agarwal ML, Stark GR, Taylor WR. p130/p107/p105Rb-dependent transcriptional repression during DNA-damage-induced cell-cycle exit at G2. Journal of Cell Science. 118: 1821-32. PMID 15827088 DOI: 10.1242/Jcs.02307  0.362
2004 Jackson MW, Agarwal MK, Agarwal ML, Agarwal A, Stanhope-Baker P, Williams BR, Stark GR. Limited role of N-terminal phosphoserine residues in the activation of transcription by p53. Oncogene. 23: 4477-87. PMID 15064747 DOI: 10.1038/Sj.Onc.1207575  0.365
2004 Lu T, Sathe SS, Swiatkowski SM, Hampole CV, Stark GR. Secretion of cytokines and growth factors as a general cause of constitutive NFkappaB activation in cancer. Oncogene. 23: 2138-45. PMID 14676835 DOI: 10.1038/Sj.Onc.1207332  0.359
2002 Li X, Stark GR. NFkappaB-dependent signaling pathways. Experimental Hematology. 30: 285-96. PMID 11937262 DOI: 10.1016/S0301-472X(02)00777-4  0.325
2002 Sizemore N, Lerner N, Dombrowski N, Sakurai H, Stark GR. Distinct roles of the Ikappa B kinase alpha and beta subunits in liberating nuclear factor kappa B (NF-kappa B) from Ikappa B and in phosphorylating the p65 subunit of NF-kappa B. The Journal of Biological Chemistry. 277: 3863-9. PMID 11733537 DOI: 10.1074/Jbc.M110572200  0.318
2002 Wagner TC, Velichko S, Vogel D, Rani MR, Leung S, Ransohoff RM, Stark GR, Perez HD, Croze E. Interferon signaling is dependent on specific tyrosines located within the intracellular domain of IFNAR2c. Expression of IFNAR2c tyrosine mutants in U5A cells. The Journal of Biological Chemistry. 277: 1493-9. PMID 11682488 DOI: 10.1074/Jbc.M108928200  0.376
2001 Girardin SE, Tournebize R, Mavris M, Page AL, Li X, Stark GR, Bertin J, DiStefano PS, Yaniv M, Sansonetti PJ, Philpott DJ. CARD4/Nod1 mediates NF-kappaB and JNK activation by invasive Shigella flexneri. Embo Reports. 2: 736-42. PMID 11463746 DOI: 10.1093/Embo-Reports/Kve155  0.303
2001 Agarwal ML, Ramana CV, Hamilton M, Taylor WR, DePrimo SE, Bean LJ, Agarwal A, Agarwal MK, Wolfman A, Stark GR. Regulation of p53 expression by the RAS-MAP kinase pathway. Oncogene. 20: 2527-36. PMID 11420662 DOI: 10.1038/Sj.Onc.1204353  0.342
2001 Gil MP, Bohn E, O'Guin AK, Ramana CV, Levine B, Stark GR, Virgin HW, Schreiber RD. Biologic consequences of Stat1-independent IFN signaling. Proceedings of the National Academy of Sciences of the United States of America. 98: 6680-5. PMID 11390995 DOI: 10.1073/Pnas.111163898  0.361
2001 Bean LJ, Stark GR. Phosphorylation of serines 15 and 37 is necessary for efficient accumulation of p53 following irradiation with UV. Oncogene. 20: 1076-84. PMID 11314044 DOI: 10.1038/Sj.Onc.1204204  0.346
2001 Taylor WR, Stark GR. Regulation of the G2/M transition by p53. Oncogene. 20: 1803-15. PMID 11313928 DOI: 10.1038/Sj.Onc.1204252  0.363
2000 Farrar JD, Smith JD, Murphy TL, Leung S, Stark GR, Murphy KM. Selective loss of type I interferon-induced STAT4 activation caused by a minisatellite insertion in mouse Stat2. Nature Immunology. 1: 65-9. PMID 10881177 DOI: 10.1038/76932  0.326
2000 Mohan RR, Mohan RR, Kim WJ, Stark GR, Wilson SE. Defective keratocyte apoptosis in response to epithelial injury in stat 1 null mice. Experimental Eye Research. 70: 485-91. PMID 10865997 DOI: 10.1006/Exer.1999.0807  0.303
2000 Ramana CV, Chatterjee-Kishore M, Nguyen H, Stark GR. Complex roles of Stat1 in regulating gene expression. Oncogene. 19: 2619-27. PMID 10851061 DOI: 10.1038/Sj.Onc.1203525  0.365
2000 Chatterjee-Kishore M, van Den Akker F, Stark GR. Adenovirus E1A down-regulates LMP2 transcription by interfering with the binding of stat1 to IRF1. The Journal of Biological Chemistry. 275: 20406-11. PMID 10764778 DOI: 10.1074/Jbc.M001861200  0.633
2000 Albrecht EB, Hunyady AB, Stark GR, Patterson TE. Mechanisms of sod2 gene amplification in Schizosaccharomyces pombe. Molecular Biology of the Cell. 11: 873-86. PMID 10712506 DOI: 10.1091/Mbc.11.3.873  0.35
2000 Chatterjee-Kishore M, van den Akker F, Stark GR. Association of STATs with relatives and friends. Trends in Cell Biology. 10: 106-11. PMID 10675904 DOI: 10.1016/S0962-8924(99)01709-2  0.662
2000 Ramana CV, Grammatikakis N, Chernov M, Nguyen H, Goh KC, Williams BRG, Stark GR. Regulation of c-myc expression by IFN-γ through Stat1-dependent and -independent pathways Embo Journal. 19: 263-272. PMID 10637230 DOI: 10.1093/Emboj/19.2.263  0.356
1999 Taylor WR, DePrimo SE, Agarwal A, Agarwal ML, Schönthal AH, Katula KS, Stark GR. Mechanisms of G2 arrest in response to overexpression of p53 Molecular Biology of the Cell. 10: 3607-3622. PMID 10564259 DOI: 10.1091/Mbc.10.11.3607  0.326
1999 Stark GR, Gudkov AV. Forward genetics in mammalian cells: Functional approaches to gene discovery Human Molecular Genetics. 8: 1925-1938. PMID 10469846 DOI: 10.1093/Hmg/8.10.1925  0.329
1999 Patterson TE, Albrecht EB, Nurse P, Sazer S, Stark GR. Effects of genome position and the DNA damage checkpoint on the structure and frequency of sod2 gene amplification in fission yeast. Molecular Biology of the Cell. 10: 2199-208. PMID 10397759 DOI: 10.1091/Mbc.10.7.2199  0.352
1999 Sizemore N, Leung S, Stark GR. Activation of phosphatidylinositol 3-kinase in response to interleukin- 1 leads to phosphorylation and activation of the NF-κB p65/RelA subunit Molecular and Cellular Biology. 19: 4798-4805. PMID 10373529 DOI: 10.1128/Mcb.19.7.4798  0.34
1999 Taylor WR, Agarwal ML, Agarwal A, Stacey DW, Stark GR. p53 inhibits entry into mitosis when DNA synthesis is blocked Oncogene. 18: 283-295. PMID 9927185 DOI: 10.1038/Sj.Onc.1202516  0.341
1998 Li X, Leung S, Burns C, Stark GR. Cooperative binding of stat1-2 heterodimers and ISGF3 to tandem DNA elements Biochimie. 80: 703-710. PMID 9865492 DOI: 10.1016/S0300-9084(99)80023-6  0.355
1998 Lackmann M, Harpur AG, Oates AC, Mann RJ, Gabriel A, Meutermans W, Alewood PF, Kerr IM, Stark GR, Wilks AF. Biomolecular interaction analysis of IFN gamma-induced signaling events in whole-cell lysates: prevalence of latent STAT1 in high-molecular weight complexes. Growth Factors (Chur, Switzerland). 16: 39-51. PMID 9777369 DOI: 10.3109/08977199809017490  0.368
1998 Stark GR, Kerr IM, Williams BRG, Silverman RH, Schreiber RD. How cells respond to interferons Annual Review of Biochemistry. 67: 227-264. PMID 9759489 DOI: 10.1146/Annurev.Biochem.67.1.227  0.373
1998 Leaman DW, Salvekar A, Patel R, Sen GC, Stark GR. A mutant cell line defective in response to double-stranded RNA and in regulating basal expression of interferon-stimulated genes Proceedings of the National Academy of Sciences of the United States of America. 95: 9442-9447. PMID 9689099 DOI: 10.1073/Pnas.95.16.9442  0.3
1998 Chernova OB, Chernov MV, Ishizaka Y, Agarwal ML, Stark GR. MYC abrogates p53-mediated cell cycle arrest in N-(phosphonacetyl)-L- aspartate-treated cells, permitting CAD gene amplification Molecular and Cellular Biology. 18: 536-545. PMID 9418900 DOI: 10.1128/Mcb.18.1.536  0.38
1997 Agarwal ML, Agarwal A, Taylor WR, Wang ZQ, Wagner EF, Stark GR. Defective induction but normal activation and function of p53 in mouse cells lacking poly-ADP-ribose polymerase Oncogene. 15: 1035-1041. PMID 9285557 DOI: 10.1038/Sj.Onc.1201274  0.373
1997 Shimoda K, Feng J, Murakami H, Nagata S, Watling D, Rogers NC, Stark GR, Kerr IM, Ihle JN. Jak1 plays an essential role for receptor phosphorylation and Stat activation in response to granulocyte colony-stimulating factor. Blood. 90: 597-604. PMID 9226159 DOI: 10.1182/Blood.V90.2.597  0.329
1997 Han Y, Watling D, Rogers NC, Stark GR. JAK2 and STAT5, but not JAK1 and STAT1, are required for prolactin- induced β-lactoglobulin transcription Molecular Endocrinology. 11: 1180-1188. PMID 9212064 DOI: 10.1210/Mend.11.8.9952  0.362
1997 Komarova EA, Chernov MV, Franks R, Wang K, Armin G, Zelnick CR, Chin DM, Bacus SS, Stark GR, Gudkov AV. Transgenic mice with p53-responsive lacZ: p53 activity varies dramatically during normal development and determines radiation and drug sensitivity in vivo Embo Journal. 16: 1391-1400. PMID 9135154 DOI: 10.1093/Emboj/16.6.1391  0.309
1997 Li X, Leung S, Kerr IM, Stark GR. Functional subdomains of STAT2 required for preassociation with the alpha interferon receptor and for signaling Molecular and Cellular Biology. 17: 2048-2056. PMID 9121453 DOI: 10.1128/Mcb.17.4.2048  0.332
1997 Smith KA, Chernova OB, Groves RP, Stark MB, Martínez JL, Davidson JN, Trent JM, Patterson TE, Agarwal A, Duncan P, Agarwal ML, Stark GR. Multiple mechanisms of N-phosphonacetyl-L-aspartate resistance in human cell lines: carbamyl-P synthetase/aspartate transcarbamylase/dihydro-orotase gene amplification is frequent only when chromosome 2 is rearranged. Proceedings of the National Academy of Sciences of the United States of America. 94: 1816-21. PMID 9050862 DOI: 10.1073/Pnas.94.5.1816  0.316
1997 Kohlhuber F, Rogers NC, Watling D, Feng J, Guschin D, Briscoe J, Witthuhn BA, Kotenko SV, Pestka S, Stark GR, Ihle JN, Kerr IM. A JAK1/JAK2 chimera can sustain alpha and gamma interferon responses. Molecular and Cellular Biology. 17: 695-706. PMID 9001223 DOI: 10.1128/Mcb.17.2.695  0.348
1996 Leaman DW, Leung S, Li X, Stark GR. Regulation of STAT-dependent pathways by growth factors and cytokines Faseb Journal. 10: 1578-1588. PMID 9002549 DOI: 10.1096/Fasebj.10.14.9002549  0.335
1996 Briscoe J, Guschin D, Rogers NC, Watling D, Müller M, Horn F, Heinrich P, Stark GR, Kerr IM. JAKs, STATs and signal transduction in response to the interferons and other cytokines. Philosophical Transactions of the Royal Society of London. Series B, Biological Sciences. 351: 167-71. PMID 8650263 DOI: 10.1098/Rstb.1996.0013  0.378
1996 Han Y, Leaman DW, Watling D, Rogers NC, Groner B, Kerr IM, Wood WI, Stark GR. Participation of JAK and STAT proteins in growth hormone-induced signaling Journal of Biological Chemistry. 271: 5947-5952. PMID 8621469 DOI: 10.1074/Jbc.271.10.5947  0.314
1996 Li X, Leung S, Qureshi S, Darnell JE, Stark GR. Formation of STAT1-STAT2 heterodimers and their role in the activation of IRF-1 gene transcription by interferon-alpha. The Journal of Biological Chemistry. 271: 5790-4. PMID 8621447 DOI: 10.1074/Jbc.271.10.5790  0.363
1995 Smith KA, Agarwal ML, Chernov MV, Chernova OB, Deguchi Y, Ishizaka Y, Patterson TE, Poupon MF, Stark GR. Regulation and mechanisms of gene amplification Philosophical Transactions of the Royal Society of London. Series B: Biological Sciences. 347: 49-56. PMID 7746853 DOI: 10.1098/Rstb.1995.0008  0.394
1995 Bandyopadhyay SK, Leonard GT, Bandyopadhyay T, Stark GR, Sen GC. Transcriptional induction by double-stranded RNA is mediated by interferon-stimulated response elements without activation of interferon-stimulated gene factor 3. The Journal of Biological Chemistry. 270: 19624-9. PMID 7642650 DOI: 10.1074/Jbc.270.33.19624  0.4
1995 Lu HT, Riley JL, Babcock GT, Huston M, Stark GR, Boss JM, Ransohoff RM. Interferon (IFN) beta acts downstream of IFN-gamma-induced class II transactivator messenger RNA accumulation to block major histocompatibility complex class II gene expression and requires the 48-kD DNA-binding protein, ISGF3-gamma. The Journal of Experimental Medicine. 182: 1517-25. PMID 7595221 DOI: 10.1084/Jem.182.5.1517  0.307
1995 Guschin D, Rogers N, Briscoe J, Witthuhn B, Watling D, Horn F, Pellegrini S, Yasukawa K, Heinrich P, Stark GR. A major role for the protein tyrosine kinase JAK1 in the JAK/STAT signal transduction pathway in response to interleukin-6. The Embo Journal. 14: 1421-9. PMID 7537214 DOI: 10.1002/J.1460-2075.1995.Tb07128.X  0.345
1993 Stark GR. Regulation and mechanisms of mammalian gene amplification Advances in Cancer Research. 61: 87-113. PMID 8346721 DOI: 10.1016/S0065-230X(08)60956-2  0.409
1993 Watling D, Guschin D, Müller M, Silvennoinen O, Witthuhn BA, Quelle FW, Rogers NC, Schindler C, Stark GR, Ihle JN, Kerr IM. Complementation by the protein tyrosine kinase JAK2 of a mutant cell line defective in the interferon-γ signal transduction pathway Nature. 366: 166-170. PMID 7901766 DOI: 10.1038/366166A0  0.341
1993 Parrington J, Rogers NC, Gewert DR, Pine R, Veals SA, Levy DE, Stark GR, Kerr IM. The interferon-stimulable response elements of two human genes detect overlapping sets of transcription factors European Journal of Biochemistry. 214: 617-626. PMID 7686487 DOI: 10.1111/J.1432-1033.1993.Tb17961.X  0.343
1991 John J, Mckendry R, Pellegrini S, Flavell D, Kerr IM, Stark GR. Isolation and characterization of a new mutant human cell line unresponsive to alpha and beta interferons Molecular and Cellular Biology. 11: 4189-4195. PMID 1906577 DOI: 10.1128/mcb.11.8.4189-4195.1991  0.309
1991 Ackrill AM, Foster GR, Laxton CD, Flavell DM, Stark GR, Kerr IM. Inhibition of the cellular response to interferons by products of the adenovirus type 5 E1A oncogene Nucleic Acids Research. 19: 4387-4393. PMID 1832217 DOI: 10.1093/Nar/19.16.4387  0.347
1989 Stark GR, Debatisse M, Giulotto E, Wahl GM. Recent progress in understanding mechanisms of mammalian DNA amplification Cell. 57: 901-908. PMID 2661014 DOI: 10.1016/0092-8674(89)90328-0  0.497
1988 Kerr SM, Stark GR, Kerr IM. Excess antisense RNA from infectious recombinant SV40 fails to inhibit expression of a transfected, interferon-inducible gene. European Journal of Biochemistry. 175: 65-73. PMID 2456924 DOI: 10.1111/J.1432-1033.1988.Tb14167.X  0.348
1984 Wells JA, Swyryd EA, Stark GR. An improved method for purifying 2',5'-oligoadenylate synthetases. The Journal of Biological Chemistry. 259: 1363-70. PMID 6693390  0.402
1984 Zieg J, Clayton CE, Ardeshir F, Giulotto E, Swyryd EA, Stark GR. Properties of single-step mutants of Syrian hamster cell lines resistant to N-(phosphonacetyl)-L-aspartate. Molecular and Cellular Biology. 3: 2089-98. PMID 6656764 DOI: 10.1128/mcb.3.11.2089-2098.1983  0.373
1984 Reid TR, Hersh CL, Kerr IM, Stark GR. Analysis of 2',5'-oligoadenylates in cells and tissues. Analytical Biochemistry. 136: 136-41. PMID 6424500 DOI: 10.1016/0003-2697(84)90315-4  0.315
1983 van der Zeijst BA, Bleumink N, Crawford LV, Swyryd EA, Stark GR. Viral proteins and RNAs in BHK cells persistently infected by lymphocytic choriomeningitis virus. Journal of Virology. 48: 262-270. DOI: 10.1128/Jvi.48.1.262-270.1983  0.302
1982 Brison O, Ardeshir F, Stark GR. General method for cloning amplified DNA by differential screening with genomic probes. Molecular and Cellular Biology. 2: 578-87. PMID 6896736 DOI: 10.1128/mcb.2.5.578-587.1982  0.383
1982 Wahl GM, Vitto L, Padgett RA, Stark GR. Single-copy and amplified CAD genes in Syrian hamster chromosomes localized by a highly sensitive method for in situ hybridization. Molecular and Cellular Biology. 2: 308-19. PMID 6180304 DOI: 10.1128/mcb.2.3.308-319.1982  0.719
1982 Padgett RA, Wahl GM, Stark GR. Properties of dispersed, highly repeated DNA within and near the hamster CAD gene. Molecular and Cellular Biology. 2: 302-7. PMID 6180303 DOI: 10.1128/mcb.2.3.302-307.1982  0.738
1982 Padgett RA, Wahl GM, Stark GR. Structure of the gene for CAD, the multifunctional protein that initiates UMP synthesis in Syrian hamster cells. Molecular and Cellular Biology. 2: 293-301. PMID 6125880 DOI: 10.1128/mcb.2.3.293-301.1982  0.748
1982 Llopis R, Stark GR. Separation and Properties of Two Kinds of Simian Virus 40 Late Transcription Complexes Journal of Virology. 44: 864-870. DOI: 10.1128/Jvi.44.3.864-870.1982  0.3
1981 Llopis R, Stark GR. Two deletions within genes for simian virus 40 structural proteins VP2 and VP3 lead to formation of abnormal transcriptional complexes. Journal of Virology. 38: 91-103. DOI: 10.1128/Jvi.38.1.91-103.1981  0.349
1980 Alwine JC, Kemp DJ, Parker BA, Reiser J, Renart J, Stark GR, Wahl GM. Detection of specific RNAs or specific fragments of DNA by fractionation in gels and transfer to diazobenzyloxymethyl paper. Methods in Enzymology. 68: 220-42. PMID 94421 DOI: 10.1016/0076-6879(79)68017-5  0.557
1979 Padgett RA, Wahl GM, Coleman PF, Stark GR. N-(Phosphonacetyl)-L-aspartate-resistant hamster cells overaccumulate a single mRNA coding for the multifunctional protein that catalyzes the first steps of UMP synthesis. The Journal of Biological Chemistry. 254: 974-80. PMID 762107  0.683
1979 Stark GR, Dower WJ, Schimke RT, Brown RE, Kerr IM. 2-5A synthetase: assay, distribution and variation with growth or hormone status. Nature. 278: 471-3. PMID 450053 DOI: 10.1038/278471A0  0.321
1979 Wahl GM, Padgett RA, Stark GR. Gene amplification causes overproduction of the first three enzymes of UMP synthesis in N-(phosphonacetyl)-L-aspartate-resistant hamster cells. The Journal of Biological Chemistry. 254: 8679-89. PMID 381311  0.703
1979 Wahl GM, Stern M, Stark GR. Efficient transfer of large DNA fragments from agarose gels to diazobenzyloxymethyl-paper and rapid hybridization by using dextran sulfate. Proceedings of the National Academy of Sciences of the United States of America. 76: 3683-7. PMID 291033 DOI: 10.1073/Pnas.76.8.3683  0.515
1979 Parker BA, Stark GR. Regulation of Simian Virus 40 Transcription: Sensitive Analysis of the RNA Species Present Early in Infections by Virus or Viral DNA Journal of Virology. 31: 360-369. DOI: 10.1128/Jvi.31.2.360-369.1979  0.338
1978 Reiser J, Renart J, Stark GR. Transfer of small DNA fragments from polyacrylamide gels to diazobenzyloxymethyl-paper and detection by hybridization with DNA probes Biochemical and Biophysical Research Communications. 85: 1104-1112. PMID 216362 DOI: 10.1016/0006-291X(78)90656-3  0.308
1978 Coleman PF, Suttle DP, Stark GR. Purification of a multifunctional protein bearing carbamyl-phosphate synthase, aspartate transcarbamylase, and dihydroorotase enzyme activities from mutant hamster cells. Methods in Enzymology. 51: 121-34. PMID 29210 DOI: 10.1016/S0076-6879(78)51020-3  0.337
1977 Kempe TD, Swyryd EA, Bruist M, Stark GR. Stable mutants of mammalian cells that overproduce the first three enzymes of pyrimidine nucleotide biosynthesis. Cell. 9: 541-50. PMID 12870 DOI: 10.1016/0092-8674(76)90036-2  0.313
1977 Alwine JC, Reed SI, Stark GR. Characterization of the Autoregulation of Simian Virus 40 Gene A Journal of Virology. 24: 22-27. DOI: 10.1128/Jvi.24.1.22-27.1977  0.542
1976 Reed SI, Stark GR, Alwine JC. Autoregulation of simian virus 40 gene A by T antigen. Proceedings of the National Academy of Sciences of the United States of America. 73: 3083-7. PMID 184459 DOI: 10.1073/Pnas.73.9.3083  0.513
1975 Reed SI, Ferguson J, Davis RW, Stark GR. T antigen binds to simian virus 40 DNA at the origin of replication. Proceedings of the National Academy of Sciences of the United States of America. 72: 1605-9. PMID 165517 DOI: 10.1073/Pnas.72.4.1605  0.51
1975 Mirault ME, Reed SI, Stark GR. An antigen associated with messenger RNA in a transformed hamster cell line. Cold Spring Harbor Symposia On Quantitative Biology. 295-303. PMID 50906 DOI: 10.1101/SQB.1974.039.01.039  0.415
1975 Alwine JC, Reed SI, Ferguson J, Stark GR. Properties of T antigens induced by wild-type SV40 and tsA mutants in lytic infection Cell. 6: 529-533. DOI: 10.1016/0092-8674(75)90042-2  0.477
1974 Yoshida T, Kretchmer N, Stark G, Hoogenraad N. INHIBITION OF CELLULAR PROLIFERATION USING AN INHIBITOR OF ASPARTATE TRANSCARBAMYLASE Pediatric Research. 8: 361-361. DOI: 10.1203/00006450-197404000-00129  0.336
1964 STARK GR, STEIN WH. ALKYLATION OF THE METHIONINE RESIDUES OF RIBONUCLEASE IN 8 M UREA. The Journal of Biological Chemistry. 239: 3755-61. PMID 14257603  0.466
1962 STARK GR, DAWSON CR. On the accessibility of sulfhydryl groups in ascorbic acid oxidase. The Journal of Biological Chemistry. 237: 712-6. PMID 13916312  0.426
Show low-probability matches.